<?xml version="1.0"?>
<rss version="2.0">
	<channel>
		<title>News in Oncology area  (category : Partnerships and Licensing).</title>
		<link>http://www.lifescience-online.com/</link>
		<description>News Feed Powered by Lifescience-online.com</description>
		<language>en-us</language>
		<pubDate>Thu, 20 Nov 2008 18:39:05 +0100</pubDate>
		<lastBuildDate>Thu, 20 Nov 2008 18:39:05 +0100</lastBuildDate>
		<category>News</category>		

		<image>
			<title>Lifescience-online</title>
			<url>http://rss.lifescience-online.com/images/logo.gif</url>
			<link>http://www.lifescience-online.com/</link>
			<width></width>
			<height></height>
			<description>Lifescience-online</description>
		</image>

		<item>
			<title>Life Science Pharmaceuticals, Inc. Enters Into Agreement with Abbott Laboratories (ABT) to Develop Antibody 806</title>
			<link>http://www.lifescience-online.com/Life_Science_Pharmaceuticals__Inc__Enters_Into_Agr,12860.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/3.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/abbott_laboratories,240.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ABBOTT LABORATORIES</u></font></a><br /><a href='http://www.lifescience-online.com/life_science_pharmaceuticals,9924.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Life Science Pharmaceuticals Inc</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/MAB-806,4796.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>MAB-806</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 16 Nov 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Curis Announces Collaborator Genentech&#039;s License of Ex-U.S. Rights to GDC-0449 to Roche</title>
			<link>http://www.lifescience-online.com/Curis_Announces_Collaborator_Genentech_s_License_o,12819.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/3.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/curis,516.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>CURIS INC</u></font></a><br /><a href='http://www.lifescience-online.com/genentech,676.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>GENENTECH INC</u></font></a><br /><a href='http://www.lifescience-online.com/roche_holding,1071.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ROCHE HOLDING LTD</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/GDC-0449,2332.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>GDC-0449</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Thu, 13 Nov 2008 13:39:20 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Marillion Pharmaceuticals and Bracco Imaging S.p.A. Announce License Agreement to Develop and Commercialize Novel Cancer Treatment</title>
			<link>http://www.lifescience-online.com/Marillion_Pharmaceuticals_and_Bracco_Imaging_S_p_A,12768.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/2.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/bracco,5268.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>BRACCO</u></font></a><br /><a href='http://www.lifescience-online.com/marillion_pharmaceuticals,10372.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Marillion Pharmaceuticals Inc</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/177LU-AMBA,1567.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>177LU-AMBA</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 11 Nov 2008 15:27:44 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>ArQule and Daiichi-Sankyo Enter Into Strategic R and D Partnership to Progress Novel Compounds to Target Cancer</title>
			<link>http://www.lifescience-online.com/ArQule_and_Daiichi_Sankyo_Enter_Into_Strategic_R_a,12705.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/3.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/arqule,333.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ARQULE INC</u></font></a><br /><a href='http://www.lifescience-online.com/daiichi_sankyo_co,9103.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>DAIICHI SANKYO CO LTD</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/ARQ-197,2355.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>ARQ-197</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 10 Nov 2008 16:03:51 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>BTG Licenses Novel Anticancer Compound to Onyx Pharmaceuticals</title>
			<link>http://www.lifescience-online.com/BTG_Licenses_Novel_Anticancer_Compound_to_Onyx_Pha,12688.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/2.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/onyx_pharmaceuticals,978.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ONYX PHARMACEUTICALS INC</u></font></a><br /><a href='http://www.lifescience-online.com/btg,5278.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>BTG PLC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/THYMIDYLATE_SYNTHASE_INHIBITORS,1761.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>THYMIDYLATE SYNTHASE INHIBITORS</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Fri, 07 Nov 2008 14:27:48 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Therapure Biopharma Inc. Announces Collaboration with BioVectra Inc.</title>
			<link>http://www.lifescience-online.com/Therapure_Biopharma_Inc__Announces_Collaboration_w,12639.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/0.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/biovectra,11017.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>BioVectra Inc</u></font></a><br /><a href='http://www.lifescience-online.com/therapure_biopharma,11018.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Therapure Biopharma Inc</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 03 Nov 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine</title>
			<link>http://www.lifescience-online.com/CEL_SCI_Announces_Expansion_of_Exclusive_Licensing,12582.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/2.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/cel-sci,453.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>CEL-SCI CORP</u></font></a><br /><a href='http://www.lifescience-online.com/orient_europharma_co,11011.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Orient Europharma Co Ltd</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/MULTIKINE,1807.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>MULTIKINE</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 02 Nov 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Biogen Idec Elects to Participate with Genentech in the Development and Commercialization of a Next Generation Anti-CD20 Molecule</title>
			<link>http://www.lifescience-online.com/Biogen_Idec_Elects_to_Participate_with_Genentech_i,12506.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/1.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/biogen_idec,382.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>BIOGEN IDEC INC</u></font></a><br /><a href='http://www.lifescience-online.com/genentech,676.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>GENENTECH INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/GA-101,3583.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>GA-101</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Wed, 29 Oct 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

	</channel>
</rss>